80945-82-0 Usage
Uses
Used in Pharmaceutical Synthesis:
2-Chloro-5-benzothiazolamine is utilized as an intermediate in the synthesis of various pharmaceutical and biologically active compounds. Its unique structure and reactivity make it a valuable component in the development of new drugs and therapeutic agents.
Used in Chemical Research:
In the field of chemical research, 2-Chloro-5-benzothiazolamine serves as a key compound for studying the properties and reactions of benzothiazoles. This helps in understanding the potential applications and limitations of these compounds in different industries, including pharmaceuticals and materials science.
Used in Material Science:
2-Chloro-5-benzothiazolamine is employed as a building block in the development of new materials with specific properties, such as conductivity, stability, or reactivity. Its incorporation into these materials can lead to advancements in areas like electronics, sensors, and energy storage.
Check Digit Verification of cas no
The CAS Registry Mumber 80945-82-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,0,9,4 and 5 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 80945-82:
(7*8)+(6*0)+(5*9)+(4*4)+(3*5)+(2*8)+(1*2)=150
150 % 10 = 0
So 80945-82-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H5ClN2S/c8-7-10-5-3-4(9)1-2-6(5)11-7/h1-3H,9H2
80945-82-0Relevant academic research and scientific papers
NADPH OXIDASE 4 INHIBITORS
-
Page/Page column 46, (2017/01/09)
The invention relates to 2,5-disubstituted benzoxazole and benzothiazole derivatives of Formula (I) Formula (I) wherein L, X, Y, and ring (A) are as described in the description, their preparation and their use as pharmaceutically active compounds. Said compounds may be useful for the prevention or treatment of diseases or disorders associated with impaired reactive oxygen species (ROS) production, and/or for the prevention or treatment of various fibrotic diseases.
INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 AND TYPE 2
-
Page/Page column 99; 100, (2010/02/06)
There is provided a compound having Formula (I): wherein one of R1 and R2 is a group of the Formula (a), wherein R4 is selected from H and hydrocarbyl, R5 is a hydrocarbyl group and L is an optional linker group, or R1 and R2 together form a ring substituted with the group (Formula (a)) wherein R3 is H or a substituent, and wherein X is selected from S, O, NR6 and C(R7)(R8), wherein R6 is selected from H and hydrocarbyl groups, wherein each of R7 and R8 are independently selected from H and hydrocarbyl groups.
